For comparison, the FDA-approved pediatric weight-management agents have substantially more strong trial records
But theres a catch: a lot of people make simple mistakes that water down their results
Together, they offer a complementary platform for studies centered on cellular migration, angiogenic signaling, and cytoskeletal modulation
While short-term preclinical studies suggest favorable safety, chronic administration effects on angiogenesis, growth factor signaling, and tissue remodeling over years of use remain unknown
To understand the full cost picture, review our [tirzepatide cost and pricing guide](/guides/tirzepatide-cost-price-guide-2026)
Translation: Researchers will continue to pursue it, but its not ready for primetime